APA (7th ed.) Citation

Chen, H., Su, P., Wang, Y., Chang, K., Su, Y., Chang, P., . . . Lai, E. C. (2023). Long‐term use and risk of major adverse cardiac events: Comparing enzalutamide and abiraterone in chemotherapy‐naïve patients with metastatic castration‐resistant prostate cancer. International journal of cancer, 152(6), 1191-1201. https://doi.org/10.1002/ijc.34348

Chicago Style (17th ed.) Citation

Chen, Hung‐Kai, et al. "Long‐term Use and Risk of Major Adverse Cardiac Events: Comparing Enzalutamide and Abiraterone in Chemotherapy‐naïve Patients with Metastatic Castration‐resistant Prostate Cancer." International Journal of Cancer 152, no. 6 (2023): 1191-1201. https://doi.org/10.1002/ijc.34348.

MLA (9th ed.) Citation

Chen, Hung‐Kai, et al. "Long‐term Use and Risk of Major Adverse Cardiac Events: Comparing Enzalutamide and Abiraterone in Chemotherapy‐naïve Patients with Metastatic Castration‐resistant Prostate Cancer." International Journal of Cancer, vol. 152, no. 6, 2023, pp. 1191-1201, https://doi.org/10.1002/ijc.34348.